Russell Investments Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-31,300
| Closed | -$748K | – | 3383 |
|
|
2021
Q1 | $748K | Buy |
+31,300
| New | +$582K | ﹤0.01% | 2358 |
|
|
2020
Q4 | – | Sell |
-117,135
| Closed | -$1.66M | – | 3273 |
|
|
2020
Q3 | $1.66M | Sell |
117,135
-26,799
| -19% | -$410K | ﹤0.01% | 1804 |
|
|
2020
Q2 | $2.11M | Sell |
143,934
-6,404
| -4% | -$65.1K | ﹤0.01% | 1594 |
|
|
2020
Q1 | $618K | Buy |
150,338
+71,732
| +91% | +$336K | ﹤0.01% | 2084 |
|
|
2019
Q4 | $376K | Buy |
78,606
+45,929
| +141% | +$253K | ﹤0.01% | 2504 |
|
|
2019
Q3 | $198K | Buy |
32,677
+2,356
| +8% | +$14.7K | ﹤0.01% | 2615 |
|
|
2019
Q2 | $197K | Sell |
30,321
-136,709
| -82% | -$963K | ﹤0.01% | 2515 |
|
|
2019
Q1 | $1.18M | Sell |
167,030
-42,140
| -20% | -$278K | ﹤0.01% | 1978 |
|
|
2018
Q4 | $1.01M | Buy |
209,170
+49,002
| +31% | +$255K | ﹤0.01% | 1949 |
|
|
2018
Q3 | $1.18M | Sell |
160,168
-12,344
| -7% | -$90.6K | ﹤0.01% | 2019 |
|
|
2018
Q2 | $1.1M | Buy |
172,512
+16,611
| +11% | +$110K | ﹤0.01% | 2077 |
|
|
2018
Q1 | $848K | Buy |
155,901
+4,903
| +3% | +$24.4K | ﹤0.01% | 2274 |
|
|
2017
Q4 | $648K | Buy |
150,998
+77,545
| +106% | +$467K | ﹤0.01% | 2344 |
|
|
2017
Q3 | $707K | Buy |
+73,453
| New | +$763K | ﹤0.01% | 2314 |
|
|
2017
Q1 | – | Sell |
-71,639
| Closed | -$895K | – | 3131 |
|
|
2016
Q4 | $895K | Buy |
+71,639
| New | +$851K | ﹤0.01% | 2231 |
|
Russell Investments Group's GNMK Position: Q2 2021 in Review
Russell Investments Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 31,300 shares — an estimated $748K sold.
Russell Investments Group first reported a position in GNMK in Q4 2016 and held it in 15 quarters. The position peaked at $2.11M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Russell Investments Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Russell Investments Group sold 31,300 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $748K.
- Russell Investments Group first reported a position in GenMark Diagnostics, Inc in Q4 2016 and held it in 15 quarters.
- Russell Investments Group's GenMark Diagnostics, Inc position peaked at $2.11M in Q2 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.